for the Digiday Programmatic Marketing Summit, May 6-8 in Palm Springs.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Puma’s AI head says the brand is still giving ‘the keys to the consumer’ as it invests in digital concierge
Puma , this month, debuted a new AI-powered “digital human” concierge named “Dylan” in its Las Vegas flagship.
The Rundown: Q1 dealmaking cools across ad tech and martech as AI remains the hottest ticket
LUMA Partners’ Q1 report notes the drag that macroeconomic uncertainty has had on dealmaking.
‘Everything is coming down’: ChatGPT ads are getting cheaper
While the pilot CPM started out at $60, advertisers are now seeing that price drop to as low as $25, just nine weeks into the test.